claim: elevated serum levels of inflammaging marker mir-146a are associated with clinical response to tocilizumab in covid-19 patients
evidence_1: we showed that covid-19 patients who did not respond to tcz have lower serum levels of mir-146a-5p after the treatment (p = 0.007).", "we showed that covid-19 patients who did not respond to tcz have lower serum levels of mir-146a-5p after the treatment (p=0.007).", "share decreased serum levels of the inflammaging marker mir-146a are associated with clinical response to tocilizumab in covid-19 patients jacopo sabbatinelli, angelica giuliani, giulia matacchione, silvia latini, noemi laprovitera, giovanni pomponio, alessia ferrarini, silvia svegliati baroni, marianna pavani, marco moretti, armando gabrielli, antonio domenico procopio, manuela ferracin, massimiliano bonafè, fabiola olivieri medrxiv 2020.07.11.20151365; doi: https://doi.org/10.1101/2020.07.11.20151365 share this article: copy citation tools decreased serum levels of the inflammaging marker mir-146a are associated with clinical response to tocilizumab in covid-19 patients jacopo sabbatinelli, angelica giuliani, giulia matacchione, silvia latini, noemi laprovitera, giovanni pomponio, alessia ferrarini, silvia svegliati baroni, marianna pavani, marco moretti, armando gabrielli, antonio domenico procopio, manuela ferracin, massimiliano bonafè, fabiola olivieri medrxiv 2020.07.11.20151365; doi: https://doi.org/10.1101/2020.07.11.20151365 ", 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  "  decreased serum levels of the inflammaging marker mir-146a are associated with clinical response to tocilizumab in covid-19 patients medrxiv - infectious diseases pub date : 2020-11-21 , doi: 10.1101/2020.07.11.20151365 jacopo sabbatinelli; angelica giuliani; giulia matacchione; silvia latini; noemi laprovitera; giovanni pomponio; alessia ferrarini; silvia svegliati baroni; marianna pavani; marco moretti; armando gabrielli; antonio domenico procopio; manuela ferracin; massimiliano bonafè; fabiola olivieri current covid-19 pandemic poses an unprecedented threat to global health and healthcare systems."
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  )